🇨🇦 Pharmacotherapy for opioid use disorder in Canada

Pharmacotherapy for opioid use disorder (Pharmacotherapy for opioid use disorder) regulatory status in Canada.

Marketing authorisation

Pharmacotherapy for opioid use disorder in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Pharmacotherapy for opioid use disorder approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Pharmacotherapy for opioid use disorder in Canada?

Boston Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.